A Herbal Remedy Exhibiting Potent Therapeutic Effects Against Covid-19: A Post-Hoc Analysis of Outpatient Clinical Observations
Abstract
Background: There is no specific evidence-based therapy with proven efficacy for COVID-19. Marecipe AV, an ancient Chinese herbal compound, has been utilized in our clinic for over a decade to treat viral infectious diseases, demonstrating remarkable therapeutic benefits. We present the outcomes of Marecipe AV herbal therapeutics in treating COVID-19 at our clinic during the outbreak in China.
Methods: The efficacy of Marecipe AV in treating COVID-19 was assessed through a comparative analysis of the duration of fever, the time to sustained resolution of clinical symptoms and the incidence of hospitalization due to progression to severe COVID-19 between a treated patient cohort and an untreated control group.
Results: Data were collected from 524 individuals diagnosed with COVID-19, of whom 159 received Marecipe AV, while 365 did not. All 122 patients treated with Marecipe AV experienced resolution of fever within 24 hours of initiating treatment, with the COVID-19 clinical course concluding within the subsequent 24 hours. The incidence of fever among the 37 individuals exposed to Omicron who were undergoing anti-tumor treatment with Marecipe was 0%, in contrast to 98% among their close contacts. Among 78 individuals at high-risk of progressing to severe COVID-19, the hospitalization rate was 0% for those treated with Marecipe AV, while it was 68% for untreated patients.
Conclusion: Marecipe AV herbal therapy has demonstrated a clear and potent therapeutic effect against COVID-19. The use of Marecipe therapeutics has the potential to terminate the clinical course of mild to moderate COVID-19 in all patients treated within a 48-hour window, while also effectively preventing the development of severe cases in all high-risk patients.
Key words: COVID-19; Herb; Herbal therapeutic; Therapy; Viral infectious diseases